Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Qingfang Li, Zhihui Li, Ting Luo, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 382-382
Open Access
An innovative approach to development of new pyrazolylquinolin-2-one hybrids as dual EGFR and BRAFV600E inhibitors
Mohamed M. Hawwas, Ahmed S. Mancy, Mohamed Ramadan, et al.
Molecular Diversity (2025)
Open Access
Metabolic reprogramming in cancer and senescence
Yuzhu Zhang, J. Tang, Can Jiang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Depletion of Acetyl‐CoA Carboxylase 1 Facilitates Epithelial‐Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway
Jiarun Lai, Shaoyou Liu, Yupeng Chen, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
Zaid Sirhan, Rawan Alojair, Anita Thyagarajan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2090-2090
Open Access | Times Cited: 12
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance
Naji Kharouf, Thomas W. Flanagan, Abdulhadi A. AlAmodi, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 240-240
Open Access | Times Cited: 4
Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy
An-Bu Liu, Jia Liu, Sheng Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Advances in Understanding Cisplatin-Induced Toxicity: Molecular Mechanisms and Protective Strategies
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106939-106939
Open Access | Times Cited: 4
Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment
Sarah Al Sharie, Dima Abu Laban, Maysa Al‐Hussaini
Cancers (2023) Vol. 15, Iss. 19, pp. 4869-4869
Open Access | Times Cited: 11
Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients
Othman R. Alzahrani, Rashid Mir, Hanan E. Alatwi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1281-1281
Open Access | Times Cited: 10
Biological function, regulatory mechanism, and clinical application of mannose in cancer
Haoyi Jin, Xi Liu, Hongxu Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188970-188970
Closed Access | Times Cited: 10
Novel pH responsive hesperidin nanoformulation exerts anticancer activity on lung adenocarcinoma cells by targeting Akt/mTOR and MEK/ERK pathways
S. R. Pavan, Ashwini Prabhu
Journal of materials research/Pratt's guide to venture capital sources (2024) Vol. 39, Iss. 8, pp. 1217-1231
Closed Access | Times Cited: 3
A comparative <i>in vitro</i> study on the effect of SGLT2 inhibitors on chemosensitivity to doxorubicin in MCF-7 breast cancer cells
Shahid Karim, Alanoud Alghanmi, Maha Jamal, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 817-830
Open Access | Times Cited: 3
Cellular and Molecular Mechanisms of Tumor Promotion
Ann M. Bode, Tianshun Zhang
Elsevier eBooks (2024)
Closed Access | Times Cited: 3
Squalene Epoxidase: Its Regulations and Links with Cancers
Lin Zhang, Zheng Cao, Yuheng Hong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3874-3874
Open Access | Times Cited: 3
Photo-triggered caffeic acid delivery via psyllium polysaccharide- gellan gum-based injectable bionanogel for epidermoid carcinoma treatment
Sirajunnisa Abdul Razack, Yeachan Lee, Sivakumar Bose, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131166-131166
Closed Access | Times Cited: 3
Comparative Analysis of Olive-Derived Phenolic Compounds’ Pro-Melanogenesis Effects on B16F10 Cells and Epidermal Human Melanocytes
Juhee Cho, Meriem Bejaoui, Ken‐ichi Tominaga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4479-4479
Open Access | Times Cited: 3
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling
Valerio Ciccone, Vittoria Simonis, Cinzia Del Gaudio, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116252-116252
Open Access | Times Cited: 3
Application and research progress of cordycepin in the treatment of tumours (Review)
Ru He, Wence Zhou
Molecular Medicine Reports (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 3
Obesity and Colorectal Cancer: A Narrative Review
Bárbara Cristina Jardim Miranda, Francisco Tustumi, E. Nakamura, et al.
Medicina (2024) Vol. 60, Iss. 8, pp. 1218-1218
Open Access | Times Cited: 3
Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
Rajibul Islam, Khor Poh Yen, Nur Najihah Izzati Mat Rani, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117877-117877
Open Access | Times Cited: 3
The Role of Bcl-2 and Beclin-1 Complex in “Switching” between Apoptosis and Autophagy in Human Glioma Cells upon LY294002 and Sorafenib Treatment
Adrian Zając, Aleksandra Maciejczyk, Joanna Sumorek-Wiadro, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2670-2670
Open Access | Times Cited: 9
MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells
Giovanni Pratelli, Daniela Carlisi, Diana Di Liberto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11149-11149
Open Access | Times Cited: 8
Glyoxalase System in Breast and Ovarian Cancers: Role of MEK/ERK/SMAD1 Pathway
Muhanad Alhujaily
Biomolecules (2024) Vol. 14, Iss. 5, pp. 584-584
Open Access | Times Cited: 2
Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
Fatima Zohra Mokhfi, Md. Al Amin, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2024) Vol. 402, pp. 111218-111218
Closed Access | Times Cited: 2

Scroll to top